[ad_1]
Vaccines available or that will be available in the European Union must meet quality and approval standards, but there may be limited exceptions that allow member states to market temporarily unauthorized products in an emergency, said a spokesman for the European Commission. Stefan De Keersmaecker added that the Member State that uses a vaccine without an EU license is responsible for marketing it. In response to a journalist’s question, the spokesperson responded that Foreign Minister Péter Szijjártó said on Thursday that Russia would begin shipping small quantities of its coronavirus vaccine to Hungary in December so that they could inspect the vaccine and complete the final steps of the process. license. office.
Richter’s request was received by OGYÉI.
The spokesperson emphasized that safety was a priority for the European Commission and that it was therefore of the utmost importance that no medicine was marketed in the EU without a marketing authorization based on a full assessment under EU law. . It is also very important that citizens have reliable information about the safety of vaccines, which is why the European Medicines Agency constantly evaluates and monitors these vaccines. As soon as a vaccine is available, the European Commission will ensure that it is launched on the market by implementing an EU vaccination strategy.
[ad_2]
